Colesevelam Oral Suspension as Monotherapy or Add-on to Metformin Therapy in Pediatric Subjects with Type 2 Diabetes Mellitus

Grants and Contracts Details

StatusFinished
Effective start/end date3/29/163/28/18

Funding

  • Daiichi Sankyo Incorporated: $22,668.00